Your Article Summary
See Latest ArticlesClinical implications of hypoxia inducible factor in renal cell carcinoma
Urologic Oncology: Seminars and Original Investigations, 06/29/09
Smaldone MC et al. - In a review of the clinical implications of hypoxia inducible factor (HIF) in renal cell carcinoma (RCC), this report provides a directed review of recent discoveries defining the role of HIF in renal tumorigenesis and their relevance to clinical advances in targeted therapy for advanced RCC.
Methods- Management of RCC has made considerable strides in the past decade, due in large part to identification of the von Hippel Lindau (VHL) tumor suppressor as a negative regulator of HIF-α protein expression.
- Stabilization of HIF-α appears to be critical for renal tumorigenesis, and is observed even in VHL-independent RCC.
- An understanding of the pathways that regulate expression and activation of the different HIF-α isoforms is key to delineating the mechanism of renal transformation and for development of novel therapeutics.
- A number of agents targeting HIF-α or its transcriptionally-regulated genes have shown promise in treatment of RCC.
- More effective treatment strategies are still needed.
Today in Kidney...keeping you current
Receive free subspecialty "5-minute updates" via email
Transplant Nephrectomy Associates with Improved Survival in Patients with Failed Renal Allograft
Journal of the American Society of Nephrology, 11/25/09
Shock Wave Lithotripsy: A Randomized, Double-blind Trial to Compare Immediate Versus Delayed Voltage Escalation
Urology, 11/23/09
A Critical Appraisal of the Value of Lymph Node Dissection at Nephroureterectomy for Upper Tract Urothelial Carcinoma
Urology, 11/05/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Is statin use associated with prostate cancer aggressiveness
BJU International, 11/09/09
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
What comes after docetaxel
Der Urologe, 11/18/09